Nutrigenomics Lab

My laboratory’s primary focus is the prevention of metabolic syndrome using nutraceuticals and the explanation of their pathophysiology. An extensive effort in the laboratory is to understand the function of nutrient-sensing genes and how the nutraceuticals rescue the disease phenotypes using a mouse, a rat, and cell-lines. Followings are our major research scope; 

 

  1. Physiological Activity Evaluation: Evaluate nutraceuticals in vivo and in vitro to prevent and/or rescue metabolic syndrome, including obesity, type II diabetes mellitus, dyslipidemia, and cardiovascular disease
  2. Nutrigenomics: Multi-omics analysis (transcriptomes, metabolomics, metagenomes, and epigenomes) to identify the candidate signaling pathway
  3. Cell Signaling: Identify/rescue pathophysiological cell signaling pathway using state-of-art molecular biology skills, including knock-down and overexpression

Nutraceuticals Evaluation

Evaluate nutraceuticals in vivo and in vitro to prevent and/or rescue metabolic syndrome, including obesity, type II diabetes mellitus, dyslipidemia, and cardiovascular disease

Nutrigenomics

Multi-omics analysis (transcriptomes, metabolomics, metagenomes, and epigenomes) to identify the candidate signaling pathway

Cell Signaling Pathways

Identify/rescue pathophysiological cell signaling pathway using state-of-art molecular biology skills, including knock-down and overexpression

In the media